Follow-on Offering

Healthcare
Follow-on Offering

Summary

Baird served as co-manager on this offering

About

Phreesia, Inc. (“Phreesia” or the “Company”) (NYSE: PHR) recently completed an underwritten secondary public offering of a total of 7,762,500 shares of its common stock by certain of Phreesia’s existing stockholders, which included the full exercise of the underwriters’ option to purchase 1,012,500 additional shares from the selling stockholders. The shares were sold at a public offering price of $26.00 per share and generated gross proceeds of approximately $201.8 million. The Company did not receive any proceeds from the sale of the shares.

Phreesia gives healthcare organizations a suite of robust applications to manage the patient intake process. The Company’s innovative SaaS platform engages patients in their healthcare and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia is headquartered in New York, New York.
CONTACT US TO LEARN MORE
Healthcare
Follow-on Offering
Date
December 2019
Company
Phreesia, Inc.
Transaction
M&A
Sectors
Healthcare
Target Location
North America

Share